Anti-Breast Cancer Compound Library

Ref. TM-L2191

Produktinformation

• Name: Anti-Breast Cancer Compound Library

Beschreibung

A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；
- Targets include HER-2, VEGF, EGFR, PARP, CDK4/6, HSP, PD-1, SET7/9, BRCA, etc.；
- Some compounds have been in market or in clinical trials;
- Detailed compound information with structure, target, and biological activity description；
- NMR and HPLC validated to ensure high purity and quality.

• Marke: Targetmol